Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles Taylor

Showing results (41-50 of 59) with videos related to

Pageof 6
Sort By:
BMC Geriatrics|September 25, 2024
Improving delirium assessments in acute senior health: A quality improvement project for care of the older personCharles Taylor, Georgia Peakman, Lauren Mackinnon, et al.
Immunity, Inflammation and Disease|October 4, 2021
The syndemic burden of HIV/AIDS in Africa amidst the COVID-19 pandemicOlivier Uwishema, Charles Taylor, Lukman Lawal, et al.
IEEE Transactions on Medical Imaging|October 7, 2024
Morphology-Based Non-Rigid Registration of Coronary Computed Tomography and Intravascular Images Through Virtual Catheter Path OptimizationKarim Kadry, Max L Olender, Andreas Schuh, et al.
Cancer Management and Research|June 6, 2017
APF530 versus ondansetron, each in a guideline-recommended three-drug regimen, for the prevention of chemotherapy-induced nausea and vomiting due to anthracycline plus cyclophosphamide-based highly emetogenic chemotherapy regimens: a post hoc subgroup analysis of the Phase III randomized MAGIC trialIan D Schnadig, Richy Agajanian, Christopher Dakhil, et al.
Medical Science Educator|December 24, 2021
Introduction of the Modified Neuroanatomy Motivation Questionnaire and Its Role in Comparing Medical Student Attitudes Towards Learning Neuroanatomy Between Neuro-enthusiasts and Standard StudentsSamuel Hall, Octavia Kurn, Deepika Anbu, et al.
European Radiology|June 23, 2019
Impact of sublingual nitroglycerin dosage on FFR<sub>CT</sub> assessment and coronary luminal volume-to-myocardial mass ratioKenneth R Holmes, Tim A Fonte, Jonathan Weir-McCall, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 29, 2014
OX40L blockade is therapeutic in arthritis, despite promoting osteoclastogenesisEmily Gwyer Findlay, Lynett Danks, Jodie Madden, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 9, 2005
Phase I clinical study of pertuzumab, a novel HER dimerization inhibitor, in patients with advanced cancerDavid B Agus, Michael S Gordon, Charles Taylor, et al.
Antimicrobial Agents and Chemotherapy|February 24, 2016
A Flow Cytometry Method for Rapidly Assessing Mycobacterium tuberculosis Responses to Antibiotics with Different Modes of ActionCharlotte Louise Hendon-Dunn, Kathryn Sarah Doris, Stephen Richard Thomas, et al.
Future Oncology (London, England)|March 22, 2016
APF530 (granisetron injection extended-release) in a three-drug regimen for delayed CINV in highly emetogenic chemotherapyIan D Schnadig, Richy Agajanian, Christopher Dakhil, et al.
Pageof 6

Showing results (41-50 of 59) with videos related to

Sort By:
Pageof 6
BMC Geriatrics|September 25, 2024
Improving delirium assessments in acute senior health: A quality improvement project for care of the older personCharles Taylor, Georgia Peakman, Lauren Mackinnon, et al.
Immunity, Inflammation and Disease|October 4, 2021
The syndemic burden of HIV/AIDS in Africa amidst the COVID-19 pandemicOlivier Uwishema, Charles Taylor, Lukman Lawal, et al.
IEEE Transactions on Medical Imaging|October 7, 2024
Morphology-Based Non-Rigid Registration of Coronary Computed Tomography and Intravascular Images Through Virtual Catheter Path OptimizationKarim Kadry, Max L Olender, Andreas Schuh, et al.
Cancer Management and Research|June 6, 2017
APF530 versus ondansetron, each in a guideline-recommended three-drug regimen, for the prevention of chemotherapy-induced nausea and vomiting due to anthracycline plus cyclophosphamide-based highly emetogenic chemotherapy regimens: a post hoc subgroup analysis of the Phase III randomized MAGIC trialIan D Schnadig, Richy Agajanian, Christopher Dakhil, et al.
Medical Science Educator|December 24, 2021
Introduction of the Modified Neuroanatomy Motivation Questionnaire and Its Role in Comparing Medical Student Attitudes Towards Learning Neuroanatomy Between Neuro-enthusiasts and Standard StudentsSamuel Hall, Octavia Kurn, Deepika Anbu, et al.
European Radiology|June 23, 2019
Impact of sublingual nitroglycerin dosage on FFR<sub>CT</sub> assessment and coronary luminal volume-to-myocardial mass ratioKenneth R Holmes, Tim A Fonte, Jonathan Weir-McCall, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 29, 2014
OX40L blockade is therapeutic in arthritis, despite promoting osteoclastogenesisEmily Gwyer Findlay, Lynett Danks, Jodie Madden, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 9, 2005
Phase I clinical study of pertuzumab, a novel HER dimerization inhibitor, in patients with advanced cancerDavid B Agus, Michael S Gordon, Charles Taylor, et al.
Antimicrobial Agents and Chemotherapy|February 24, 2016
A Flow Cytometry Method for Rapidly Assessing Mycobacterium tuberculosis Responses to Antibiotics with Different Modes of ActionCharlotte Louise Hendon-Dunn, Kathryn Sarah Doris, Stephen Richard Thomas, et al.
Future Oncology (London, England)|March 22, 2016
APF530 (granisetron injection extended-release) in a three-drug regimen for delayed CINV in highly emetogenic chemotherapyIan D Schnadig, Richy Agajanian, Christopher Dakhil, et al.
Pageof 6